GSK Statistics
Total Valuation
GSK plc has a market cap or net worth of $80.66 billion. The enterprise value is $96.53 billion.
| Market Cap | 80.66B |
| Enterprise Value | 96.53B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | Feb 22, 2024 |
Share Statistics
GSK plc has 2.03 billion shares outstanding.
| Shares Outstanding | 2.03B |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 14.42% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 13.18 and the forward PE ratio is 10.32. GSK plc's PEG ratio is 1.09.
| PE Ratio | 13.18 |
| Forward PE | 10.32 |
| PS Ratio | 2.10 |
| Forward PS | 2.51 |
| PB Ratio | 4.89 |
| P/FCF Ratio | 11.90 |
| PEG Ratio | 1.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.05, with an EV/FCF ratio of 14.24.
| EV / Earnings | 15.48 |
| EV / Sales | 2.51 |
| EV / EBITDA | 12.05 |
| EV / EBIT | 12.05 |
| EV / FCF | 14.24 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 1.35.
| Current Ratio | 0.89 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | 2.78 |
| Debt / FCF | 3.29 |
| Interest Coverage | 8.18 |
Financial Efficiency
Return on equity (ROE) is 38.70% and return on invested capital (ROIC) is 18.64%.
| Return on Equity (ROE) | 38.70% |
| Return on Assets (ROA) | 8.30% |
| Return on Capital (ROIC) | 18.64% |
| Revenue Per Employee | $546,771 |
| Profits Per Employee | $88,845 |
| Employee Count | 70,212 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.61 |
Taxes
In the past 12 months, GSK plc has paid $935.10 million in taxes.
| Income Tax | 935.10M |
| Effective Tax Rate | 13.04% |
Stock Price Statistics
The stock price has increased by +7.64% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
| Beta (1Y) | 0.27 |
| 52-Week Price Change | +7.64% |
| 50-Day Moving Average | 41.87 |
| 200-Day Moving Average | 37.77 |
| Relative Strength Index (RSI) | 33.18 |
| Average Volume (30 Days) | 3,588,332 |
Short Selling Information
| Short Interest | 4.83M |
| Short Previous Month | 4.76M |
| Short % of Shares Out | 0.72% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.83 |
Income Statement
In the last 12 months, GSK plc had revenue of $38.39 billion and earned $6.24 billion in profits. Earnings per share was $2.97.
| Revenue | 38.39B |
| Gross Profit | 26.92B |
| Operating Income | 8.34B |
| Pretax Income | 7.03B |
| Net Income | 6.24B |
| EBITDA | 8.01B |
| EBIT | 8.01B |
| Earnings Per Share (EPS) | $2.97 |
Balance Sheet
The company has $6.41 billion in cash and $22.29 billion in debt, giving a net cash position of -$15.88 billion or -$7.82 per share.
| Cash & Cash Equivalents | 6.41B |
| Total Debt | 22.29B |
| Net Cash | -15.88B |
| Net Cash Per Share | -$7.82 |
| Equity / Book Value | 16.51B |
| Book Value Per Share | 8.14 |
| Working Capital | -3.00B |
Cash Flow
In the last 12 months, operating cash flow was $8.37 billion and capital expenditures -$1.59 billion, giving a free cash flow of $6.78 billion.
| Operating Cash Flow | 8.37B |
| Capital Expenditures | -1.59B |
| Free Cash Flow | 6.78B |
| FCF Per Share | $3.34 |
Margins
Gross margin is 70.12%, with operating and profit margins of 21.73% and 16.25%.
| Gross Margin | 70.12% |
| Operating Margin | 21.73% |
| Pretax Margin | 18.31% |
| Profit Margin | 16.25% |
| EBITDA Margin | 20.87% |
| EBIT Margin | 20.87% |
| FCF Margin | 17.66% |
Dividends & Yields
This stock pays an annual dividend of $1.62, which amounts to a dividend yield of 4.07%.
| Dividend Per Share | $1.62 |
| Dividend Yield | 4.07% |
| Dividend Growth (YoY) | 5.36% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.32% |
| Buyback Yield | -0.62% |
| Shareholder Yield | 3.45% |
| Earnings Yield | 7.73% |
| FCF Yield | 8.41% |
Analyst Forecast
The average price target for GSK plc is $46.00, which is 15.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $46.00 |
| Price Target Difference | 15.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 4.45% |
| EPS Growth Forecast (5Y) | -4.75% |
Stock Splits
The last stock split was on July 22, 2022. It was a forward split with a ratio of 1226:1000.
| Last Split Date | Jul 22, 2022 |
| Split Type | Forward |
| Split Ratio | 1226:1000 |
Scores
GSK plc has an Altman Z-Score of 1.86 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.86 |
| Piotroski F-Score | 7 |